Status:
UNKNOWN
Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C
Lead Sponsor:
Sun Yat-sen University
Conditions:
Recurrent Pterygium
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this randomized clinical trial is to compare the efficacy and safety of intraoperative mitomycin C(MMC) combined with limbal conjunctival autograft(LCAG) or conjunctival autograft(CAG) ...
Detailed Description
Intraoperative mitomycin C after pterygium excision is widely used to prevent recurrce of recurrent pterygium. Conjunctival autograft with or without limbal tissue used to cover the bare sclera will e...
Eligibility Criteria
Inclusion
- Recurrent pterygium
- Willingness to participate in research project and to attend research time
- At least 6 months after last pterygium surgery
Exclusion
- Pregnant,breast-feeding women or poor general health
- Patients with significant ocular or lid pathology, such as Sjogren's Syndrome ,infection, exposure keratitis,glaucoma and trauma
- Patients with allergy to mitomycin C,tobramycin or local anesthetics
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04463901
Start Date
February 1 2016
End Date
July 1 2021
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060